Trump Administration's Reclassification of Marijuana
The Trump administration has reclassified state-licensed medical marijuana from Schedule I to Schedule III under the Controlled Substances Act, a move that significantly eases restrictions and could impact future legalization efforts.
Latest Developments
What marijuana's reclassification means for public health and businesses
The federal government is reclassifying medical marijuana, moving it to a category that acknowledges its potential medical benefits and lower potential for harm. This action, reported by William Brangham, marks a significant shift in federal drug policy by recognizing cannabis's therapeutic uses. While this reclassification does not federally legalize marijuana nationwide, it is expected to facilitate increased scientific research into its effects. This change could have implications for public health understanding and for businesses operating in the cannabis industry.
What to know about Trump’s reclassification of state-licensed medical marijuana
Acting Attorney General Todd Blanche, under President Trump’s direction, signed an order on Thursday to reclassify state-licensed medical marijuana as a less-dangerous drug. This action represents a significant shift in U.S. policy regarding cannabis regulation. While the move does not federally legalize marijuana, it will impact how the drug is regulated in the numerous states that currently permit its use for medical purposes. This reclassification could reduce federal enforcement priorities and ease restrictions on research and medical access.
Trump reclassifies state-licensed medical marijuana as less-dangerous drug
President Trump has reclassified state-licensed medical marijuana as a less-dangerous drug, according to an order signed by Todd Blanche. This action changes how medical marijuana is regulated at the federal level, though it does not federally legalize its medical or recreational use. The reclassification could reduce federal penalties for some marijuana-related offenses and potentially ease research restrictions. This move marks a significant shift in federal drug policy concerning cannabis.
Trump reclassifies state-licensed medical marijuana as a less-dangerous drug in a historic shift - AP News
President Donald Trump has reclassified state-licensed medical marijuana as a less-dangerous drug. This action marks a historic shift in federal drug policy regarding cannabis. The reclassification could significantly alter how medical marijuana is regulated and researched at the federal level. It also impacts states where medical cannabis is currently legal, potentially easing conflicts between state and federal law. This move represents a major change in the federal government's stance on marijuana's medical utility.
US reclassifies cannabis, raising possibility of marijuana legalisation - BBC
The United States government has reclassified cannabis, moving it from Schedule I to Schedule III under the Controlled Substances Act. This administrative action acknowledges cannabis's accepted medical uses and lower potential for abuse compared to drugs like heroin. The reclassification significantly reduces federal restrictions on cannabis, potentially easing research and medical access. This change, initiated by the Department of Health and Human Services and approved by the Drug Enforcement Administration, could pave the way for broader state-level medical marijuana programs and impact federal banking and tax policies for cannabis businesses. While not outright federal legalization, it marks a historic shift in federal drug policy regarding marijuana.
Key Facts
President Donald Trump signed an executive order to accelerate research into hallucinogens and increase access to them.
Source: The Guardian US News
The Trump administration reclassified state-licensed medical marijuana to a less dangerous drug category.
Source: AP Top News
The Justice Department's order moves cannabis from Schedule I to Schedule III under the Controlled Substances Act.
Source: CBS News
Acting Attorney General Todd Blanche signed the order reclassifying state-licensed medical marijuana.
Source: ABC News
Recent Highlights
President Trump signed an executive order to accelerate research into hallucinogens.
Acting Attorney General Todd Blanche signed an order reclassifying state-licensed medical marijuana as a less dangerous drug.
Full Coverage (11 articles)
What marijuana's reclassification means for public health and businesses
The federal government is reclassifying medical marijuana, moving it to a category that acknowledges its potential medical benefits and lower potential for harm. This action, reported by William Brangham, marks a significant shift in federal drug policy by recognizing cannabis's therapeutic uses. While this reclassification does not federally legalize marijuana nationwide, it is expected to facilitate increased scientific research into its effects. This change could have implications for public health understanding and for businesses operating in the cannabis industry.
What to know about Trump’s reclassification of state-licensed medical marijuana
Acting Attorney General Todd Blanche, under President Trump’s direction, signed an order on Thursday to reclassify state-licensed medical marijuana as a less-dangerous drug. This action represents a significant shift in U.S. policy regarding cannabis regulation. While the move does not federally legalize marijuana, it will impact how the drug is regulated in the numerous states that currently permit its use for medical purposes. This reclassification could reduce federal enforcement priorities and ease restrictions on research and medical access.
Trump reclassifies state-licensed medical marijuana as less-dangerous drug
President Trump has reclassified state-licensed medical marijuana as a less-dangerous drug, according to an order signed by Todd Blanche. This action changes how medical marijuana is regulated at the federal level, though it does not federally legalize its medical or recreational use. The reclassification could reduce federal penalties for some marijuana-related offenses and potentially ease research restrictions. This move marks a significant shift in federal drug policy concerning cannabis.
Trump reclassifies state-licensed medical marijuana as a less-dangerous drug in a historic shift - AP News
President Donald Trump has reclassified state-licensed medical marijuana as a less-dangerous drug. This action marks a historic shift in federal drug policy regarding cannabis. The reclassification could significantly alter how medical marijuana is regulated and researched at the federal level. It also impacts states where medical cannabis is currently legal, potentially easing conflicts between state and federal law. This move represents a major change in the federal government's stance on marijuana's medical utility.
US reclassifies cannabis, raising possibility of marijuana legalisation - BBC
The United States government has reclassified cannabis, moving it from Schedule I to Schedule III under the Controlled Substances Act. This administrative action acknowledges cannabis's accepted medical uses and lower potential for abuse compared to drugs like heroin. The reclassification significantly reduces federal restrictions on cannabis, potentially easing research and medical access. This change, initiated by the Department of Health and Human Services and approved by the Drug Enforcement Administration, could pave the way for broader state-level medical marijuana programs and impact federal banking and tax policies for cannabis businesses. While not outright federal legalization, it marks a historic shift in federal drug policy regarding marijuana.
Justice Department eases restrictions on some marijuana products
The Justice Department has eased restrictions on certain marijuana products, reclassifying them to a lower drug classification. This order specifically applies to FDA-approved products containing marijuana and state-regulated medical marijuana products. This move could significantly alter how these specific cannabis products are regulated at the federal level. It represents a shift in federal drug policy regarding certain marijuana-derived substances and medical cannabis.
‘Can I have some, please?’: has Trump opened the door to a psychedelic future?
President Donald Trump signed a landmark executive order in the Oval Office to accelerate research into hallucinogens and increase access to them. The order, signed on "Bicycle Day," specifically mentioned the psychedelic ibogaine. This action is hailed as a "threshold moment" for the future of psychedelics, marking a significant shift in federal policy. However, concerns persist regarding how access will be managed and what protections will be put in place for individuals.
Trump administration reclassifies cannabis as less dangerous
The Trump administration reclassified cannabis, moving it into a category of drugs on par with Tylenol with codeine. This action aims to increase research into marijuana and expand access to the substance. The reclassification signifies a significant shift in federal drug policy regarding cannabis. This change could facilitate new medical applications and scientific studies by reducing regulatory hurdles. The move reflects an effort by the White House to address the evolving understanding of cannabis's potential benefits and risks.
Trump administration moves to ease federal restrictions on marijuana
The Trump administration has moved to reclassify marijuana from schedule I to schedule III under the Controlled Substances Act. This action follows President Donald Trump's executive order, signed more than four months prior, directing the attorney general to initiate the change. Previously, marijuana shared the same schedule I classification as drugs like heroin and LSD, indicating a high potential for abuse and no accepted medical use. The reclassification to schedule III acknowledges some medical use and a lower potential for abuse, marking a significant shift in federal drug policy. This change could impact research, medical access, and federal enforcement related to cannabis.
State-licensed medical marijuana reclassified as less dangerous drug
Acting Attorney General Todd Blanche signed an order on Thursday reclassifying state-licensed medical marijuana as a less dangerous drug. This action changes how the federal government views cannabis used for medical purposes under state licensing. The reclassification could reduce federal penalties for activities involving state-licensed medical marijuana and ease restrictions on research. This move by the Trump administration aligns federal policy more closely with states that have legalized medical cannabis.
Trump administration reclassifies state-licensed medical marijuana as less dangerous drug
Acting Attorney General Todd Blanche signed an order reclassifying state-licensed medical marijuana as a less dangerous drug on Thursday. This order shifts licensed medical marijuana from a high level of regulation to a much looser one. The reclassification also provides a tax break to licensed medical marijuana operators. This move by the Trump administration does not legalize marijuana but significantly alters its federal oversight.